Retrospective review of eyes with neovascular age-related macular degeneration treated with photodynamic therapy with verteporfin and intravitreal triamcinolone

Annals of the Academy of Medicine Singapore

Volumn 35, Issue 10, 2006, Pages 701-705

  Fackler, Tamara K ^a   Reddy, Shantan ^b   Bearelly, Srilaxmi ^a   Stinnett, Sandra ^a   Fekrat, Sharon ^a   Cooney, Michael J ^c  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b EAR AND THROAT HOSPITAL   (United States)

^c VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

Author keywords

Choroidal neovascularisation; Macular degeneration; Photodynamic therapy; Triamcinolone; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; TRIAMCINOLONE;

AGED; ANGIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33751580124     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9.
2. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-21.
3. Dastgheib K, Green WR. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol 1994;112:813-8.
4. Killingsworth MC, Sarks JP, Sarks JH. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 1990;4:613-21.
5. Oh H, Takagi H, Takagi C, Suzuma K, Otani A, Ishida K, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1990;40:1891-8.
6. Schmidt-Erfurth U, Miller J, Sickenberg M, Bunse A, Laqua H, Gragoudas E, et al. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol 1998;236:365-74.
7. Schmidt-Erfurth U, Michels A, Barbazettol, Laqua H. The photodynamic effects of choroidal neovascularization and physiological choroids. Invest Ophthalmol Vis Sci 2002;43:830-41.
8. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E Jr. Treatment with intravitreal steroids reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992;110:1155-9.
9. Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 1985;103:708-11.
10. Ciulla TA, Criswell MH, Danis RP, Hill TE. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 2001;119:399-404.
11. Antoszyk AN, Gottlieb JL, Machemer R, Hatchell DL. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefes Arch Clin Exp Ophthalmol 1993;231:34-40.
12. Penfold PL, Wen L, Madigan MC, King NJ, Provis JM. Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci 2002;43:3125-30.
13. Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2005;112:301-4.
14. Rechtman W, Danis RP, Pratt LM, Harris A. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. Br J Ophthamol 2005;88:344-7.
15. Augustin AJ, Schmidt-Erfurth U. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology 2006;113:14-22.
16. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one year results of 2 randomized clinical trials-TAP report 1. Arch Ophthalmol 1999;117:1329-45.
17. Chylack LT Jr, Leske MC, Khu P, McCarthy D, Wu SY. Strategies for measuring the rate of age-related cataract formation in vivo. Lens Eye Toxic Res 1989;6:515-22.
18. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two year-results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-60.
19. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-91.
20. rd, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthlamol 1984;102:1640-1.
21. Miller JW, Walsh AW, Kramer M, Hasan T, Michaud N, Flotte TJ, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein delivered benzoporphyrin. Arch Ophthalmol 1995;12:810-8.
22. Schmidt-Erfurth U, Hassan T, Gragoudas E, Michaud N, Flotte TJ, Birngruber R. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 1994;101:1953-61.
23. Schmidt-Erfurth U, Hassan T, Schomacker K, Flotte T, Birngruber R. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Laser Surg Med 1995;17:178-88.
24. Kvanta A, Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1996;37:1929-34.
25. Gehrs KM, Heriot WJ, de Juan E Jr. Transmission electron microscopic study of subretinal choroidal neovascular membrane due to age-related macular degeneration. Arch Ophthlamol 1992;110:833-7.
26. Lopez PF, Grossiklaus HE, Lamber JM, Aaberg TM, Capone A Jr, Sternberg P Jr, et al. Pathological features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 1991;112:647-56.
27. Penfold PL, Provis JM, Billson FA. Age-related macular degeneration: ultrastructural studies of the relationship of leukocytes to angiogenesis. Graefes Arch Clin Exp Ophthalmol 1987;225:70-6.
28. Penfold PL, Killingsworth M, Sarks SH. An ultrastructural study of the role of leukocytes and fibroblasts in the breakdown of Bruch's membrane. Aust J Ophthlamol 1984;12:23-31.
29. Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular generation and intravitreal triamcinolone. A pilot study. Aust N Z J Ophthalmol 1995;23:293-9.
30. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthlamol 1998;26:277-81.
31. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244.
32. Penfold PL, Wong JG, Gyory J, Billson FA. Effects of triamcinolone acetonide of microglial morphology and quantitative expression on MHC II in exudative age-related macular degeneration. Clin Exp Ophthalmol 2001;29:188-92.
33. McCuen BW II, Bessler M, Tano Y, Chandler D, Machemer R. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981;91:785-8.